Knoll Capital Management, LLC Krystal Biotech, Inc. Transaction History

Knoll Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$33.17 - $65.23 $3.99 Million - $7.84 Million	-120,212 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$34.72 - $51.3 $933,204 - $1.38 Million	-26,878 Reduced 18.27%	120,212 $4.17 Million
Q2 2019 Aug 14, 2019	SELL	$27.2 - $41.2 $1.71 Million - $2.59 Million	-62,896 Reduced 29.95%	147,090 $5.92 Million
Q1 2019 May 15, 2019	SELL	$19.86 - $32.9 $1.79 Million - $2.96 Million	-90,014 Reduced 30.0%	209,986 $6.91 Million
Q3 2017 Nov 14, 2017	BUY	$9.75 - $10.64 $2.93 Million - $3.19 Million	300,000	300,000 $2.99 Million

300

24.3M

388K

233K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.41B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.